(Q38027604)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Guidelines for treatment of atopic eczema (atopic dermatitis) Part II (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

European Dermatology Forum

8 February 2020

object named as

European Dermatology Forum

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

J Ring

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A Alomar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

T Bieber

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

M Deleuran

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A Fink-Wagner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

C Gelmetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

U Gieler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

J Lipozencic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

T Luger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A P Oranje

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

T Schäfer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

T Schwennesen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

S Seidenari

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

D Simon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

G Stingl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

S Szalai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A Taïeb

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

T Werfel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A Wollenberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

U Darsow

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

European Academy of Dermatology and Venereology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

European Task Force on Atopic Dermatitis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

European Federation of Allergy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

European Society of Pediatric Dermatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Global Allergy and Asthma European Network

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

19 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

Journal of the European Academy of Dermatology and Venereology

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

1176-1193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

Cutaneous sensory nerves: mediators of phototherapeutic effects?

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Gene expression of cytokines in atopic eczema before and after ultraviolet A1 phototherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Biopositive effects of low-dose UVB on epidermis: coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Heliotherapy improves vitamin D balance and atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

What's new in atopic eczema? An analysis of the clinical significance of systematic reviews on atopic eczema published in 2006 and 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Broadband UVB revisited: is the narrowband UVB fad limiting our therapeutic options?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

5-Methoxypsoralen plus ultraviolet (UV) A is superior to medium-dose UVA1 in the treatment of severe atopic dermatitis: a randomized crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Targeted UVB-308 nm (NUVB) therapy with excimer laser in the treatment of atopic dermatitis and other inflammatory dermatoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Management of atopic dermatitis using photo(chemo)therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

A pilot study showing pulsed-dye laser treatment improves localized areas of chronic atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Comparison of cyclosporin and UVAB phototherapy for intermittent one-year treatment of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Comparison of two formulations of cyclosporin A in the treatment of severe atopic dermatitis. Aa double-blind, single-centre, cross-over pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

A randomized trial of methotrexate versus azathioprine for severe atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Recombinant interferon gamma therapy for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Successful interferon alpha therapy in atopic dermatitis of Besnier's prurigo pattern with normal serum IgE and blood eosinophil fraction: randomized case-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Treatment of atopic eczema with oral alitretinoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Alefacept for moderate to severe atopic dermatitis: a pilot study in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Efalizumab for severe atopic dermatitis: a pilot study in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Efalizumab for severe refractory atopic eczema: retrospective study on 11 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Allergen-specific Immunotherapy in Atopic Eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Immunotherapy in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Complementary therapy for atopic eczema and other allergic skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

The essence of alternative medicine. A dermatologist's view from Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Complementary medicine in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Alternative medicine in allergies - prevalence, patterns of use, and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, U.S.A. and U.K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Atopic eczema unresponsive to evening primrose oil (linoleic and gamma-linolenic acids).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Evening primrose oil is effective in atopic dermatitis: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Gamma-linolenic-acid-rich borage seed oil capsules in children with atopic dermatitis. A placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Efficacy of dietary hempseed oil in patients with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

A double-blind, randomized, placebo-controlled trial of n-3 versus n-6 fatty acid-based lipid infusion in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Herbal therapy in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

A randomized, double-blind, vehicle-controlled, half-side comparison with a herbal ointment containing Mahonia aquifolium, Viola tricolor and Centella asiatica for the treatment of mild-to-moderate atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Adverse effects of herbal drugs in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Stealth triamcinolone acetonide in a phytocosmetic cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Traditional Chinese medicine for the treatment of dermatologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

The treatment of eczema with Chinese herbs: a systematic review of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Acupuncture, electrostimulation, and reflex therapy in dermatology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Influence of acupuncture on type I hypersensitivity itch and the wheal and flare response in adults with atopic eczema - a blinded, randomized, placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Randomized, double-blind, placebo-controlled trial of autologous blood therapy for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Efficacy trial of bioresonance in children with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

The usage of complementary therapies by dermatological patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Homeopathic treatment of Japanese patients with intractable atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Atopic dermatitis symptoms decreased in children following massage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Indications, contraindications and possible side‐effects of climatotherapy at the Dead‐Sea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Postnatal somatic and mental development after periconceptional multivitamin supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Evaluation of dietary intake of vitamin E in the treatment of atopic dermatitis: a study of the clinical course and evaluation of the immunoglobulin E serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Topical vitamin B12--a new therapeutic approach in atopic dermatitis-evaluation of efficacy and tolerability in a randomized placebo-controlled multicentre clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Evaluation of Topical Vitamin B12 for the Treatment of Childhood Eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Atopic dermatitis and psychological stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

The effect of combined topical steroids and habit-reversal treatment in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Pediatric atopic eczema: the impact of an educational intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Effectiveness of a multidisciplinary itch-coping training programme in adults with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Structured education program improves the coping with atopic dermatitis in children and their parents-a multicenter, randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Eczema workshops reduce severity of childhood atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Three years of Italian experience of an educational program for parents of young children affected by atopic dermatitis: improving knowledge produces lower anxiety levels in parents of children with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

A review of the impact and effectiveness of nurse-led care in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Substitution of doctors by nurses in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Cross-cultural development of a child health care questionnaire on satisfaction, utilization, and needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Educational programmes for young people with eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

The information needs and preferred roles in treatment decision-making of parents caring for infants with atopic dermatitis: a qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Involuntary autonomy: patients' perceptions of physicians, conventional medicines and risks in the management of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

A guide for education programs in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Compliance among patients with atopic eczema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Written action plans: potential for improving outcomes in children with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

The status of Internet access in adult patients with atopic dermatitis in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

Treatment of atopic dermatitis: A comparison of psychological and dermatological approaches to relapse prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04636.X

10.1111/J.1468-3083.2012.04636.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22813359%20AND%20SRC:MED&resulttype=core&format=json